Consensus CME Group Inc.

Equities

CME

US12572Q1058

Financial & Commodity Market Operators

Market Closed - Nasdaq Other stock markets 21:00:00 12/12/2025 GMT			5-day change	1st Jan Change
273.55 ^USD	+0.88%		+0.99%	+17.79%

12-12	Barclays Adjusts CME Group Price Target to $304 From $280, Maintains Equalweight Rating	MT
12-12	Euronext extends trading hours for agricultural commodities futures	RE

Evolution of the Average Target: CME Group Inc.

Evolution of the Target Price: CME Group Inc.

Changes in Analyst Recommendations: CME Group Inc.

cd.gfJusmuv9Kyle4OqCVEDxq5LUueFOyiUKDeJUejWedw.6ZgW6lPBq_PoLLvZaxwx9eM-YIvJWGTtZnDNJY-7SZ70xyvcD_XHgcwxsw~4175170c2508ad91542d8584f09a06aa

Analysts' recommendations: CME Group Inc.

12-12	Barclays Adjusts CME Group Price Target to $304 From $280, Maintains Equalweight Rating	MT
12-10	BofA Securities Adjusts CME Group Price Target to $209 From $201	MT
12-05	RBC Raises Price Target on CME Group to $295 From $282, Keeps Sector Perform Rating	MT
12-04	Goldman Sachs Adjusts Price Target on CME Group to $263 From $264, Maintains Sell Rating	MT
11-28	November's Final Verdict
11-25	Goldman Sachs Adjusts Price Target on CME Group to $264 From $263, Maintains Sell Rating	MT
11-17	US Equity Markets End Lower as Expectations for December Interest Rate Cut Continue to Fall	MT
11-14	Deutsche Bank Adjusts Price Target on CME Group to $310 From $300, Maintains Buy Rating	MT
11-13	Piper Sandler Adjusts Price Target on CME Group to $313 From $296, Maintains Overweight Rating	MT
11-06	Rothschild & Co Redburn Adjusts CME Group Price Target to $300 From $297, Maintains Neutral Rating	MT
10-31	Argus Research Adjusts CME Group Price Target to $295 From $308	MT
10-23	CME Group Seen as Defensive Beneficiary With New Growth Vectors, Morgan Stanley Says	MT
10-23	CME Group's Growth Initiatives Seen Sustaining Earnings Momentum Into 2026, Deutsche Bank Says	MT
10-23	UBS Adjusts Price Target on CME Group to $280 From $285, Maintains Neutral Rating	MT
10-23	Deutsche Bank Upgrades CME Group to Buy From Hold, Raises Price Target to $300 From $266	MT
10-23	TD Cowen Adjusts Price Target on CME Group to $290 From $288, Maintains Hold Rating	MT
10-23	Goldman Sachs Adjusts Price Target on CME Group to $263 From $262, Maintains Sell Rating	MT
10-23	Morgan Stanley Lifts Price Target on CME Group to $314 From $312, Keeps Overweight Rating	MT
10-22	TD Cowen Adjusts Price Target on CME Group to $290 From $288, Maintains Hold Rating	MT
10-14	JPMorgan Adjusts Price Target on CME Group to $256 From $252, Maintains Underweight Rating	MT
10-13	Raymond James Adjusts CME Group to $307 From $309, Maintains Outperform Rating	MT
10-13	Keefe Bruyette & Woods Adjusts PT on CME Group to $287 From $283, Keeps Market Perform Rating	MT
10-10	Jefferies Adjusts Price Target on CME Group to $304 From $313, Maintains Buy Rating	MT
10-09	Deutsche Bank Adjusts CME Group Price Target to $266 From $276, Maintains Hold Rating	MT
10-08	Barclays Adjusts Price Target on CME Group to $280 From $298, Maintains Equalweight Rating	MT

More recommendations

Sector Comparison:

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	CME GROUP INC.					+4.6%
	TRADEWEB MARKETS INC.					+19.15%
	BSE LIMITED					-1.29%
	JAPAN EXCHANGE GROUP, INC.					+2.56%
	ASX LIMITED					+13.76%
	MULTI COMMODITY EXCHANGE OF INDIA LIMITED					-0.51%
	SAUDI TADAWUL GROUP HOLDING COMPANY					+22.64%
	DUBAI FINANCIAL MARKET					+3.86%
	MIAMI INTERNATIONAL HOLDINGS, INC.					+14.22%
	BOURSA KUWAIT SECURITIES COMPANY K.P.S.C.					+7.27%
	Average					+8.63%
	Weighted average by Cap.					+6.93%

See all sector consensus

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

273.55USD

Average target price

286.13USD

Spread / Average Target

+4.60%

High Price Target

314.00USD

Spread / Highest target

+14.79%

Low Price Target

209.00USD

Spread / Lowest Target

-23.60%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

Barclays
BofA Securities
RBC Capital Markets
Goldman Sachs
Deutsche Bank Securities
Piper Sandler
Rothschild & Co Redburn
Argus
UBS
TD Cowen
Morgan Stanley
JPMorgan Chase
Raymond James
Keefe Bruyette & Woods
Jefferies & Co.
Citigroup
Oppenheimer
Redburn Atlantic
Autonomous Research
Rosenblatt Securities
Keefe, Bruyette & Woods
Credit Suisse
Atlantic Equities
Berenberg Bank
Wells Fargo Securities